Louie SG - Search Results

1

Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy.

Dai Z, Zhang XN, Cheng Q, Fei F, Hou T, Li J, Abdolvahabi A, Watanabe J, Pei H, Smbatyan G, Xie J, Lenz HJ, Louie SG, Zhang Y. Dai Z, et al. Among authors: louie sg. J Control Release. 2021 Aug 10;336:433-442. doi: 10.1016/j.jconrel.2021.06.041. Epub 2021 Jun 29. J Control Release. 2021. PMID: 34197861 Free PMC article.

2

Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.

Garcia AA, Pujari M, Jeffers S, Iqbal S, Lenz HJ, Beringer P, Louie S. Garcia AA, et al. Cancer Chemother Pharmacol. 2005 Jul;56(1):75-82. doi: 10.1007/s00280-004-0940-9. Epub 2005 Apr 5. Cancer Chemother Pharmacol. 2005. PMID: 15809878 Clinical Trial.

3

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

LaBonte MJ, Manegold PC, Wilson PM, Fazzone W, Louie SG, Lenz HJ, Ladner RD. LaBonte MJ, et al. Among authors: louie sg. Int J Cancer. 2009 Dec 15;125(12):2957-69. doi: 10.1002/ijc.24658. Int J Cancer. 2009. PMID: 19536776 Free article.

4

The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models.

LaBonte MJ, Wilson PM, Fazzone W, Russell J, Louie SG, El-Khoueiry A, Lenz HJ, Ladner RD. LaBonte MJ, et al. Among authors: louie sg. Cancer Res. 2011 May 15;71(10):3635-48. doi: 10.1158/0008-5472.CAN-10-2430. Epub 2011 Apr 4. Cancer Res. 2011. PMID: 21464044 Free PMC article.

5

The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.

Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ. Ning Y, et al. Among authors: louie sg. Mol Cancer Ther. 2012 Jun;11(6):1353-64. doi: 10.1158/1535-7163.MCT-11-0915. Epub 2012 Mar 5. Mol Cancer Ther. 2012. PMID: 22391039

6

A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.

Shah M, Edman MC, Janga SR, Shi P, Dhandhukia J, Liu S, Louie SG, Rodgers K, Mackay JA, Hamm-Alvarez SF. Shah M, et al. Among authors: louie sg. J Control Release. 2013 Nov 10;171(3):269-79. doi: 10.1016/j.jconrel.2013.07.016. Epub 2013 Jul 25. J Control Release. 2013. PMID: 23892265 Free PMC article.

7

Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin.

Sheng X, Parmentier JH, Tucci J, Pei H, Cortez-Toledo O, Dieli-Conwright CM, Oberley MJ, Neely M, Orgel E, Louie SG, Mittelman SD. Sheng X, et al. Among authors: louie sg. Mol Cancer Res. 2017 Dec;15(12):1704-1713. doi: 10.1158/1541-7786.MCR-17-0338. Epub 2017 Nov 8. Mol Cancer Res. 2017. PMID: 29117945 Free PMC article.

8

Simultaneous quantitation of folates, flavins and B₆ metabolites in human plasma by LC-MS/MS assay: Applications in colorectal cancer.

Asante I, Pei H, Zhou E, Liu S, Chui D, Yoo E, Louie SG. Asante I, et al. Among authors: louie sg. J Pharm Biomed Anal. 2018 Sep 5;158:66-73. doi: 10.1016/j.jpba.2018.05.030. Epub 2018 May 22. J Pharm Biomed Anal. 2018. PMID: 29860180 Free PMC article.

9

Chronic intermittent nicotine delivery via lung alveolar region-targeted aerosol technology produces circadian pharmacokinetics in rats resembling human smokers.

Shao XM, Liu S, Lee ES, Fung D, Pei H, Liang J, Mudgway R, Zhang J, Feldman JL, Zhu Y, Louie S, Xie XS. Shao XM, et al. J Appl Physiol (1985). 2018 Nov 1;125(5):1555-1562. doi: 10.1152/japplphysiol.00357.2018. Epub 2018 Sep 20. J Appl Physiol (1985). 2018. PMID: 30236046 Free PMC article.

10

Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.

Asante I, Pei H, Zhou E, Liu S, Chui D, Yoo E, Conti DV, Louie SG. Asante I, et al. Among authors: louie sg. Mol Omics. 2019 Feb 11;15(1):21-29. doi: 10.1039/c8mo00158h. Mol Omics. 2019. PMID: 30515501 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page